122 related articles for article (PubMed ID: 8650746)
1. The diagnostic utility of serum ferritin. Estimation in patients with primary hepatocellular carcinoma.
Ola SO; Akanji AO; Ayoola EA
Trop Geogr Med; 1995; 47(6):302-4. PubMed ID: 8650746
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic utility of serum ferritin estimation in Nigerian patients with primary hepatocellular carcinoma.
Ola SO; Akanji AO; Ayoola EA
Nutrition; 1995; 11(5 Suppl):532-4. PubMed ID: 8748215
[TBL] [Abstract][Full Text] [Related]
3. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
Khin LW; Teo CJ; Guan R
Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
[TBL] [Abstract][Full Text] [Related]
6. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD
J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668
[TBL] [Abstract][Full Text] [Related]
7. Differential tumor markers and hepatitis markers profile in liver tumors.
Khalifa A; Mady EA; Abadeer N; Kamal A
Anticancer Res; 1999; 19(4A):2495-500. PubMed ID: 10470181
[TBL] [Abstract][Full Text] [Related]
8. [A retrospective study of the serum CEA, AFP, TPA and ferritin values in 500 patients with chronic liver diseases].
Cioffi M; Fratta M; De Lucia D; Bresciani F
Arch Monaldi Mal Torace; 1990; 45(3):159-65. PubMed ID: 1726999
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of liver diseases using serum biomarkers.
Cujic D; Golubovic S; Bojic-Trbojevic Z; Ilic N; Baricevic I; Nedic O
J BUON; 2010; 15(1):141-6. PubMed ID: 20414942
[TBL] [Abstract][Full Text] [Related]
10. HBsAg, aflatoxins and primary hepatocellular carcinoma.
Olubuyide IO; Maxwell SM; Hood H; Neal GE; Hendrickse RG
Afr J Med Med Sci; 1993 Sep; 22(3):89-91. PubMed ID: 7839921
[TBL] [Abstract][Full Text] [Related]
11. Serum alphafoetoprotein, hepatitis B virus infection and primary hepatocellular carcinoma in Nigerians.
Ola SO; Olubuyide IO; Ayoola EA
East Afr Med J; 1994 Dec; 71(12):782-3. PubMed ID: 7535684
[TBL] [Abstract][Full Text] [Related]
12. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
Hsu PI; Chow NH; Lai KH; Yang HB; Chan SH; Lin XZ; Cheng JS; Huang JS; Ger LP; Huang SM; Yen MY; Yang YF
Anticancer Res; 1997; 17(4A):2803-9. PubMed ID: 9252719
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma.
Nakagawa N; Ikoma J; Ishihara T; Yasui N; Fujita N; Iwasa M; Kaito M; Watanabe S; Adachi Y
Cancer; 1999 Oct; 86(8):1437-40. PubMed ID: 10526270
[TBL] [Abstract][Full Text] [Related]
14. Serum alpha-1-antitrypsin and alpha-1-antichymotrypsin in the diagnosis of primary hepatocellular carcinoma.
Xu KC; Wei Q; Meng XY
Chin Med J (Engl); 1989 Nov; 102(11):834-8. PubMed ID: 2561553
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
[TBL] [Abstract][Full Text] [Related]
16. [The occurrence and significance of the presence of alpha fetoprotein (AFP) and Australia antigen (HBsAg) in the serum of 392 patients with chronic disease and primary malignant neoplasms of the liver].
Stajić M; Milosavljević J
Acta Med Iugosl; 1978; 32(3):243-51. PubMed ID: 80098
[No Abstract] [Full Text] [Related]
17. [Etiologic fraction and interaction of risk factors for primary hepatocellular carcinoma in Wenzhou, Zhejiang Province].
Zou CL; Chen ZJ; Jin WY; Ni SC; Chen BF; Hu YL
Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Sep; 37(5):355-7. PubMed ID: 14680600
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of serum ferritin in primary hepatocellular carcinoma.
Giannoulis E; Arvanitakis C; Nikopoulos A; Doutsos I; Tourkantonis A
Digestion; 1984; 30(4):236-41. PubMed ID: 6210220
[TBL] [Abstract][Full Text] [Related]
19. What can be revealed by extending the sensitivity of HBsAg detection to below the present limit?
Togashi H; Hashimoto C; Yokozawa J; Suzuki A; Sugahara K; Saito T; Yamaguchi I; Badawi H; Kainuma N; Aoyama M; Ohya H; Akatsuka T; Tanaka Y; Mizokami M; Kawata S
J Hepatol; 2008 Jul; 49(1):17-24. PubMed ID: 18479773
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
